PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 6 months ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2025 incluant les dates de publication des résultats et de l'assemblée générale, visant à informer les investisseurs et actionnaires Immunothérapie Événements Financiers Innate Pharma Biotechnologies Calendrier Financier 2025
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 6 months ago Inside Information / Other news releases Innate Pharma releases its 2025 financial calendar including key publication dates for financial statements and shareholder meetings Financial Statements Investors Financial Calendar 2025 Innate Pharma
BRIEF published on 11/08/2024 at 07:05, 1 year 6 months ago Innate Pharma présente ses innovations en oncologie au SITC 2024 Immunothérapie Innate Pharma NK Cell Engager SITC 2024 Conjugué Anticorps-médicament
BRIEF published on 11/08/2024 at 07:05, 1 year 6 months ago Innate Pharma presents its innovations in oncology at SITC 2024 Immunotherapy Innate Pharma SITC 2024 NK Cell Engage Antibody-drug Conjugate
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 6 months ago Informations privilégiées / Autres communiqués Annonce de Innate Pharma sur les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 Immunothérapie Oncologie ADC Innate Pharma SITC 2024
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 6 months ago Inside Information / Other news releases Innate Pharma announces new preclinical data on IPH6501 and IPH4502 to be presented at SITC Annual Meeting 2024. Advances in immunotherapy reflected in drug development progress Drug Development Preclinical Data Immunotherapy Innate Pharma SITC Annual Meeting 2024
PRESS RELEASE published on 09/12/2024 at 13:09, 1 year 8 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 06/17/2024 at 07:05, 1 year 11 months ago Innate Pharma dévoile des résultats prometteurs pour le SAR443579/IPH6101 dans des cancers du sang Sanofi Innate Pharma SAR443579 Leucémie Cancer Du Sang
BRIEF published on 06/17/2024 at 07:05, 1 year 11 months ago Innate Pharma reveals promising results for SAR443579/IPH6101 in blood cancers Sanofi Innate Pharma SAR443579 Leukemia Blood Cancer
PRESS RELEASE published on 06/17/2024 at 07:00, 1 year 11 months ago Informations privilégiées / Autres communiqués Innate Pharma présente de nouveaux résultats sur l'essai de phase 1/2 mené par Sanofi évaluant le NK Cell Engager SAR443579/IPH6101 dans divers cancers du sang lors du congrès annuel de l'EHA 2024 Étude De Phase 1/2 Innate Pharma NK Cell Engager SAR443579/IPH6101 Cancers Du Sang
Published on 05/28/2026 at 12:30, 29 minutes ago White Gold Corp. Commences 2026 Exploration Program Designed to Further Increase Known Gold Resources and Make New Discoveries on its District Scale Land Package in Yukon, Canada
Published on 05/28/2026 at 10:30, 2 hours 29 minutes ago Caldwell Strengthens Financial Services and Fintech Capabilities with Addition of Alex Langridge in London
Published on 05/28/2026 at 10:10, 2 hours 49 minutes ago Powering Macau's Smart Future with AI - MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:05, 3 hours 54 minutes ago Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 3 hours 58 minutes ago Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia
Published on 05/28/2026 at 12:30, 29 minutes ago Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Published on 05/28/2026 at 12:25, 34 minutes ago Infosys and Roland-Garros Serve Up AI-Powered Digital Fan Experiences, Extend Partnership Through 2031
Published on 05/28/2026 at 11:50, 1 hour 9 minutes ago Energiekontor AG: Energiekontor resolves share cancellation
Published on 05/28/2026 at 11:38, 1 hour 21 minutes ago EQS-Adhoc: Energiekontor AG: Energiekontor AG resolves to buy back shares
Published on 05/28/2026 at 11:05, 1 hour 54 minutes ago Omdia Q1 2026: Hisense Strengthens Global Leadership in 100-inch+ TVs
Published on 05/28/2026 at 10:30, 2 hours 29 minutes ago Recticel Group opgenomen in Financial Times-lijst van Europese Klimaatleiders
Published on 05/28/2026 at 10:30, 2 hours 29 minutes ago Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders
Published on 05/28/2026 at 08:45, 4 hours 14 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 4 hours 14 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 4 hours 29 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
